Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals

MicroPET imaging of HER2+ tumors using F-18-labeled anti-HER2 diabody

Shannon Sirk, Sebastian Olma, Clifton Shen, Eric Lepin, Kan Liu, Tove Olafsen and Anna Wu
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 492;
Shannon Sirk
1UCLA, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Olma
1UCLA, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clifton Shen
1UCLA, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Lepin
1UCLA, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kan Liu
1UCLA, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tove Olafsen
1UCLA, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Wu
1UCLA, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 50 no. supplement 2 492

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Shannon Sirk1,
  2. Sebastian Olma1,
  3. Clifton Shen1,
  4. Eric Lepin1,
  5. Kan Liu1,
  6. Tove Olafsen1 and
  7. Anna Wu1
  1. 1UCLA, Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Los Angeles, CA

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2015 to April 2025

AbstractFullPdf
Jan 2015200
Feb 2015200
Mar 2015100
Apr 2015300
May 2015200
Jun 2015100
Sep 2015700
Dec 2015100
Feb 2016100
Mar 2016100
Apr 2016100
May 2016200
Jul 2016200
Sep 2016200
Oct 2016300
Nov 2016500
Dec 2016700
Jan 2017700
Feb 2017500
Mar 2017400
Apr 2017500
May 2017600
Jun 2017100
Sep 20171500
Oct 2017100
Nov 2017100
Dec 2017100
Feb 2018100
Mar 2018100
Apr 2018200
May 2018100
Jun 2018100
Jul 2018100
Sep 2018400
Oct 2018300
Feb 2019400
Mar 2019200
Jul 2019100
Sep 2019200
Jan 2020300
Feb 2020400
Mar 20201400
Apr 2020900
May 2020300
Jun 2020200
Jul 2020400
Aug 20209800
Sep 202014300
Oct 20201400
Nov 20202600
Dec 2020700
Jan 2021600
Feb 20211600
Mar 20211100
Apr 20211100
May 2021800
Jun 2021300
Jul 20211400
Aug 20213300
Sep 20211300
Oct 20211900
Nov 20215800
Dec 20213100
Jan 20226100
Feb 20221900
Mar 20221700
Apr 20222100
May 20222100
Jun 2022800
Aug 2022300
Sep 2022100
Oct 2022300
Mar 2023200
Apr 2023400
May 2023200
Jun 2023100
Jul 2023200
Aug 2023500
Sep 2023100
Oct 2023500
Nov 2023100
Dec 2023300
Jan 2024400
Mar 2024200
Apr 2024300
May 2024300
Jun 2024100
Aug 20241200
Sep 2024900
Oct 2024300
Nov 2024700
Dec 2024200
Jan 2025100
Mar 2025200
Apr 2025500
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
MicroPET imaging of HER2+ tumors using F-18-labeled anti-HER2 diabody
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
MicroPET imaging of HER2+ tumors using F-18-labeled anti-HER2 diabody
Shannon Sirk, Sebastian Olma, Clifton Shen, Eric Lepin, Kan Liu, Tove Olafsen, Anna Wu
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 492;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
MicroPET imaging of HER2+ tumors using F-18-labeled anti-HER2 diabody
Shannon Sirk, Sebastian Olma, Clifton Shen, Eric Lepin, Kan Liu, Tove Olafsen, Anna Wu
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 492;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals

  • Analysis of tumor uptake of Iod-123-Methyltyrosine in fused PET-MRI in a mouse xenotransplantation model of pancreatic cancer
  • Evaluation of [64Cu]DOTA-annexin V radiotracer in the cycloheximide-induced liver apoptosis model
  • PET imaging of α-galactosidase A pharmacokinetics in rats and monkeys
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals

Oncology I

  • Highly potent bombesin antagonist for PET and SPECT imaging of GRPr positive tumors: Effect of chelates on affinity and pharmacokinetics of radioligands
  • The role of megalin in the renal uptake of radiolabeled peptides
  • A Ga-68 labeled peptide for imaging of αvβ6 positive tumor
Show more Oncology I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire